Noaber

Noaber is a purpose-driven venture fund based in the Netherlands, with a mission to create meaningful and sustainable healthcare solutions. The firm invests in early-stage ventures that drive impactful innovations in healthcare, focusing on improving health outcomes while reducing costs and increasing both patient and provider satisfaction. Noaber’s investment strategy revolves around the “Quadruple Aim” of healthcare, which seeks to improve the overall health of populations, enhance the patient experience, reduce healthcare costs, and improve the work life of healthcare providers. The fund’s core investment areas include health activation, early screening and diagnostics, chronic disease management, and health system innovation. Examples of Noaber’s portfolio include Alba Health, which uses microbiome science and AI to prevent chronic diseases, and Momo Medical, which supports caregivers in nursing homes through advanced patient monitoring technology. Another noteworthy investment is Habitual, a digital intervention program that helps manage type 2 diabetes by providing scalable, cost-effective patient support. Noaber is heavily involved in the (pre-)seed stage and frequently serves as the first professional investor in companies. Although its primary focus is on ventures in the Benelux region, Germany, Austria, Switzerland, and Scandinavia, Noaber is expanding its reach through strategic partnerships, including plans to enter the U.S. market. In addition to direct investments, Noaber also participates in investment funds that share its vision for driving healthcare innovation. Noaber’s approach is hands-on, fostering close collaborations with entrepreneurs to inspire broader investment in socially impactful healthcare innovations.